Pulmatrix PULM Stock
Pulmatrix Price Chart
Pulmatrix PULM Financial and Trading Overview
| Pulmatrix stock price | 1.5 USD |
| Previous Close | 1.46 USD |
| Open | 1.46 USD |
| Bid | 1.35 USD x 1400 |
| Ask | 1.23 USD x 100 |
| Day's Range | 1.41 - 1.62 USD |
| 52 Week Range | 1.16 - 7.99 USD |
| Volume | 174.51K USD |
| Avg. Volume | 66.73K USD |
| Market Cap | 5.62M USD |
| Beta (5Y Monthly) | 1.943 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.23 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PULM Valuation Measures
| Enterprise Value | 3.25M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.3422222 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.1300137 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Pulmatrix Stock Price History
| Beta (5Y Monthly) | 1.943 |
| 52-Week Change | -78.15% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 7.99 USD |
| 52 Week Low | 1.16 USD |
| 50-Day Moving Average | 1.33 USD |
| 200-Day Moving Average | 2.94 USD |
PULM Share Statistics
| Avg. Volume (3 month) | 66.73K USD |
| Avg. Daily Volume (10-Days) | 189.22K USD |
| Shares Outstanding | 3.65M |
| Float | 3.65M |
| Short Ratio | 1.49 |
| % Held by Insiders | 0.74% |
| % Held by Institutions | 9.02% |
| Shares Short | 24.83K |
| Short % of Float | 0.68% |
| Short % of Shares Outstanding | 0.67% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.96% |
| Return on Equity (ttm) | -84.29% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -38000 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -4526000 USD |
| Diluted EPS (ttm) | -1.23 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.32M USD |
| Total Cash Per Share (mrq) | 0.91 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.96 |
| Book Value Per Share (mrq) | 0.723 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4687000 USD |
| Levered Free Cash Flow (ttm) | -3693750 USD |
Profile of Pulmatrix
| Country | United States |
| State | MA |
| City | Framingham |
| Address | 945 Concord Street |
| ZIP | 01701 |
| Phone | 888 355 4440 |
| Website | https://www.pulmatrix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.
Q&A For Pulmatrix Stock
What is a current PULM stock price?
Pulmatrix PULM stock price today per share is 1.5 USD.
How to purchase Pulmatrix stock?
You can buy PULM shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pulmatrix?
The stock symbol or ticker of Pulmatrix is PULM.
Which industry does the Pulmatrix company belong to?
The Pulmatrix industry is Biotechnology.
How many shares does Pulmatrix have in circulation?
The max supply of Pulmatrix shares is 3.65M.
What is Pulmatrix Price to Earnings Ratio (PE Ratio)?
Pulmatrix PE Ratio is now.
What was Pulmatrix earnings per share over the trailing 12 months (TTM)?
Pulmatrix EPS is -1.23 USD over the trailing 12 months.
Which sector does the Pulmatrix company belong to?
The Pulmatrix sector is Healthcare.
Pulmatrix PULM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
146.53 USD — |
-0.75
|
— — | 144.14 USD — | 148.72 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31560.2 USD — |
-2.21
|
— — | 31469.2 USD — | 31924.72 USD — | — - | — — |
- {{ link.label }} {{link}}